INSIGHTS AT POLARIS: Expert advice, news, and what's new at Polaris.
In June 2013, the EFPIA (European Federation of Pharmaceutical Industries and Associations) Statutory General Assembly adopted the “EFPIA code”, a code set by industry self-regulation, requiring its 33 national member associations to publicly report the transfers of value (ToV) madeLearn More
AMERICAS TRANSPARENCY Significant Payments of Other Sorts ("SPOOS”) are a part of the FDA’s financial disclosure regulations, not CMS’s open payments requirements. “SPOOS” include payments made by a sponsor of aRead more
Investment in long-term compliance solutions is on the rise. Three factors are driving that increased spending. The life sciences industry has faced many challenges in 2016 as global regulations andRead more
The final deadline for publication and submission of reports of transparency disclosures required by the European Federation of Pharmaceutical Industry Associations (EFPIA) arrived on June 30, 2016. Companies have nowRead more